Major roles of the circadian clock in cancer

被引:24
作者
Huang, Chen [1 ,2 ]
Zhang, Chenliang [3 ]
Cao, Yubin [4 ]
Li, Jian [5 ]
Bi, Feng [1 ,2 ]
机构
[1] Sichuan Univ, West China Hosp, Canc Ctr, Dept Abdominal Oncol, Chengdu 610000, Peoples R China
[2] Sichuan Univ, West China Hosp, Lab Mol Targeted Therapy Oncol, Chengdu 610000, Peoples R China
[3] Sichuan Univ, West China Hosp, Lab Mol Targeted Therapy Oncol, Chengdu 610000, Peoples R China
[4] Sichuan Univ, West China Hosp, Dept Gastroenterol, Chengdu 610000, Peoples R China
[5] Sichuan Univ, West China Sch Med, Chengdu 610000, Peoples R China
基金
中国国家自然科学基金;
关键词
Circadian clock; BMAL1; cancer; tumor therapy; oncology; NUCLEAR FACTOR 4-ALPHA; CELL-PROLIFERATION; HEPATOCELLULAR-CARCINOMA; NEDD8-ACTIVATING ENZYME; COLORECTAL-CANCER; TUMOR-GROWTH; GENE PER1; TRANSCRIPTIONAL REGULATION; RHYTHM DISRUPTION; COLON-CANCER;
D O I
10.20892/j.issn.2095-3941.2022.0474
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Circadian rhythms are natural rhythms that widely exist in all creatures, and regulate the processes and physiological functions of various biochemical reactions. The circadian clock is critical for cancer occurrence and progression. Its function is regulated by metabolic activities, and the expression and transcription of various genes. This review summarizes the composition of the circadian clock; the biological basis for its function; its relationship with, and mechanisms in, cancer; its various functions in different cancers; the effects of anti-tumor treatment; and potential therapeutic targets. Research in this area is expected to advance understanding of circadian locomotor output cycles kaput (CLOCK) and brain and muscle ARNT-like protein 1 (BMAL1) in tumor diseases, and contribute to the development of new anti-tumor treatment strategies.
引用
收藏
页码:1 / 24
页数:24
相关论文
共 50 条
  • [31] Exploiting the Circadian Clock for Improved Cancer Therapy: Perspective From a Cell Biologist
    Kuo, Tia Tyrsett
    Ladurner, Andreas G.
    FRONTIERS IN GENETICS, 2019, 10
  • [32] Watching the clock: endoplasmic reticulum-mediated control of circadian rhythms in cancer
    Pluquet, Olivier
    Dejeans, Nicolas
    Chevet, Eric
    ANNALS OF MEDICINE, 2014, 46 (04) : 233 - 243
  • [33] Disruption of the Molecular Circadian Clock and Cancer: An Epigenetic Link
    Hernandez-Rosas, Fabiola
    Alberto Lopez-Rosas, Carlos
    Virginia Saavedra-Velez, Margarita
    BIOCHEMICAL GENETICS, 2020, 58 (01) : 189 - 209
  • [34] Circadian rhythmicity and the influence of 'clock' genes on prostate cancer
    Kiss, Zsofia
    Ghosh, Paramita M.
    ENDOCRINE-RELATED CANCER, 2016, 23 (11) : T123 - T134
  • [35] Circadian clock synchrony and chronotherapy opportunities in cancer treatment
    Damato, Anna R.
    Herzog, Erik D.
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2022, 126 : 27 - 36
  • [36] The circadian clock and the hypoxic response pathway in kidney cancer
    Mazzoccoli, Gianluigi
    De Cata, Angelo
    Piepoli, Ada
    Vinciguerra, Manlio
    TUMOR BIOLOGY, 2014, 35 (01) : 1 - 7
  • [37] Disruption of the Molecular Circadian Clock and Cancer: An Epigenetic Link
    Fabiola Hernández-Rosas
    Carlos Alberto López-Rosas
    Margarita Virginia Saavedra-Vélez
    Biochemical Genetics, 2020, 58 : 189 - 209
  • [38] Circadian clock and cancer: From a viewpoint of cellular differentiation
    Tsuchiya, Yoshiki
    Umemura, Yasuhiro
    Yagita, Kazuhiro
    INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 (06) : 518 - 524
  • [39] Circadian clock-mediated nuclear receptors in cancer
    Niu, Ya
    Tang, Shuang
    JOURNAL OF CELLULAR PHYSIOLOGY, 2022, 237 (12) : 4428 - 4442
  • [40] Circadian Clock Manipulation for Cancer Prevention and Control and the Relief of Cancer Symptoms
    Hrushesky, William J. M.
    Grutsch, James
    Wood, Patricia
    Yang, Xiaoming
    Oh, Eun-Young
    Ansell, Christine
    Kidder, Stephanie
    Ferrans, Carol
    Quiton, Dinah Faith T.
    Reynolds, Justin
    Du-Quiton, Jovelyn
    Levin, Robert
    Lis, Christopher
    Braun, Donald
    INTEGRATIVE CANCER THERAPIES, 2009, 8 (04) : 387 - 397